Hers is the women-focused side of the Hims & Hers Health platform (HIMS on NYSE). Its weight loss vertical sells compounded semaglutide with marketing tailored to women, including content on hormonal and metabolic factors that affect weight in female patients.<\/p>\n
TrimRx is a unisex compounded GLP-1 provider that prescribes both semaglutide and tirzepatide. The platform doesn’t segment by gender; it focuses on the medication and clinician relationship regardless of patient profile.<\/p>\n
This comparison covers pricing, medications, clinician access, and the women-specific considerations that matter when picking between these two providers.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
Hers is the women-focused brand within Hims & Hers Health (HIMS).<\/strong> The weight loss vertical launched in 2023 alongside the broader Hims weight loss program. Hers prescribes compounded semaglutide injections for adult women, with marketing content addressing hormonal and metabolic factors specific to women.<\/p>\n Quick Answer: Hers Weight Loss prescribes compounded semaglutide at $199-$249 per month standard pricing<\/p>\n The clinical model is async-first with licensed clinicians who review intake and prescribe. The platform also offers other women’s health categories including birth control, mental health, hair loss, and skincare.<\/p>\n Pricing for compounded semaglutide ranges $199-$249 per month at standard rates, with promotional first-month rates often below $99. The Hers app provides educational content and patient communication.<\/p>\n TrimRx is a unisex telehealth platform that prescribes compounded semaglutide and tirzepatide.<\/strong> The intake is a free assessment quiz followed by clinician review and personalized treatment plan. Medication ships from licensed US 503A and 503B compounding pharmacies.<\/p>\n The platform doesn’t segment by gender. The intake captures relevant medical history including reproductive status, hormonal conditions, and other factors that affect GLP-1 prescribing, but the marketing and product positioning are neutral.<\/p>\n Pricing is transparent: $199 entry for semaglutide, $299 for tirzepatide. Quarterly and annual prepay options reduce the rate by 10-20%.<\/p>\n Hers and TrimRx semaglutide entry pricing is similar, both around $199 per month at standard rates.<\/strong> Hers runs promotional first-month rates that can drop below $99, with standard pricing resuming month two.<\/p>\n For tirzepatide, TrimRx has the clear advantage: $299 per month at standard pricing. Hers doesn’t routinely offer tirzepatide as a standard option.<\/p>\n Annual cost for typical semaglutide patient: $2,400-$3,500 at either provider. Tirzepatide patients need TrimRx or another provider that carries it.<\/p>\n Hers offers compounded semaglutide as the primary GLP-1 option.<\/strong> Some markets may include oral options. Hers doesn’t routinely offer brand-name Wegovy\u00ae, brand-name Zepbound\u00ae, or compounded tirzepatide at standard cash-pay rates.<\/p>\n TrimRx offers compounded semaglutide and compounded tirzepatide. No brand-name, no oral options, no other obesity medications.<\/p>\n For women considering tirzepatide specifically, TrimRx is the path. SURMOUNT-1 (Jastreboff et al. 2022 NEJM) showed tirzepatide produced 20.9% weight loss at 72 weeks, versus 14.9% for semaglutide in STEP 1.<\/p>\n Yes, several. PCOS, perimenopause, thyroid conditions, and pregnancy planning all interact with GLP-1 prescribing.<\/p>\n PCOS patients often see improved insulin sensitivity and weight loss on GLP-1 medications. Some studies suggest tirzepatide may be more effective in PCOS due to the GIP component, though dedicated PCOS trials are still in progress.<\/p>\n Perimenopausal patients face metabolic changes that complicate weight loss. GLP-1 medications work but may have different timing and side effect profiles in this group.<\/p>\n Pregnancy is an absolute contraindication for GLP-1 medications. STEP 1 excluded pregnant patients. Both Hers and TrimRx screen for pregnancy at intake; women trying to conceive should not start GLP-1 therapy.<\/p>\n Both providers run async-first models.<\/strong> Patients message clinicians through a patient portal with replies within 24 hours typically.<\/p>\n Hers clinicians work across the women’s health platform, handling birth control, mental health, and other categories alongside weight loss. The clinical staff is licensed but covers broad therapeutic areas.<\/p>\n TrimRx clinicians work exclusively in compounded GLP-1 prescribing. The narrower focus generally produces more specific titration advice and side effect management.<\/p>\n Hers bundles compounded medication, clinician messaging, shipping, the Hers app with educational content, and integration with the broader Hers account.<\/strong> Women’s health content (cycle tracking, hormonal information) is built into some app features.<\/p>\n TrimRx bundles compounded medication, clinician messaging, dose titration support, and shipping. No proprietary app, no women’s health content.<\/p>\n If you’ll use the Hers app and women’s health content actively, that bundle has value. If you won’t, both providers deliver similar core service.<\/p>\n Key Takeaway: Hers doesn’t routinely offer tirzepatide; TrimRx does<\/p>\n Hers reviews for weight loss specifically (separating from other Hers products) sit in the 4.0-4.5 star range.<\/strong> Positive themes: pricing, convenience, women-focused content. Negative themes: post-promotional pricing surprises, cancellation friction.<\/p>\n TrimRx reviews for weight loss sit in the same 4.0-4.5 star range. Positive themes: transparent pricing, clinician responsiveness, tirzepatide access. Negative themes: limited in-app coaching.<\/p>\n Both providers attract loyalty from the patient profiles they serve best. Hers’ women-focused marketing lands with women who want gender-specific content. TrimRx’s unisex focus on medication and clinician access fits patients who don’t want a heavy app layer.<\/p>\n The active ingredient (semaglutide) is the same at both providers.<\/strong> STEP 1 outcomes apply to the active ingredient at appropriate dosing.<\/p>\n Real-world reviews at both providers report 10-15% weight loss on consistent semaglutide dosing over 6+ months, matching the trial trajectory. Tirzepatide users (only at TrimRx) report 12-20% weight loss matching SURMOUNT-1.<\/p>\n Patient adherence and titration to therapeutic dose matter more than provider brand. STEP 1 showed weight loss accelerates after the first 20 weeks; patients who stop early see proportionally smaller results.<\/p>\n Choose Hers if you want women-focused content, you already use Hers for other women’s health categories, or you specifically prefer compounded semaglutide without considering tirzepatide.<\/strong><\/p>\n Choose TrimRx if you want access to compounded tirzepatide, you prefer a unisex platform without gender-specific framing, or you value transparent pricing without promotional revert mechanics.<\/p>\n Run the free TrimRx assessment quiz for a personalized price quote. Compare to Hers’ intake quote. Both intakes are free.<\/p>\n PCOS patients often see improved insulin sensitivity and weight loss on GLP-1 medications.<\/strong> Small studies suggest tirzepatide may be more effective for PCOS due to the dual GIP\/GLP-1 mechanism, though dedicated PCOS trials are still in progress. Hers, focused on compounded semaglutide, can prescribe for PCOS but doesn’t offer tirzepatide. TrimRx offers both options.<\/p>\n Perimenopausal patients face shifting metabolic physiology. Estrogen decline interacts with insulin sensitivity, body composition, and energy expenditure. GLP-1 medications still work in perimenopause but may have different timing and side effect profiles. Both Hers and TrimRx clinicians screen for menopausal status at intake.<\/p>\n Pregnancy is an absolute contraindication for GLP-1 medications. STEP 1 excluded pregnant patients. Women trying to conceive should not start GLP-1 therapy; women on treatment who become pregnant should stop immediately and consult primary care.<\/p>\n The major trials (STEP 1, SURMOUNT-1) included women but didn’t separately analyze outcomes by hormonal status.<\/strong> Real-world data from registries suggests similar weight loss in women and men, with women sometimes reporting more pronounced GI side effects during titration.<\/p>\n Bone density is a long-term consideration for menopausal patients losing significant weight on GLP-1 medications. Standard recommendation is adequate dietary protein (1.0-1.2 g\/kg body weight) and resistance training to preserve lean mass. Neither Hers nor TrimRx provides dedicated DEXA scans or bone density monitoring; that’s primary care territory.<\/p>\n Cycle changes have been reported anecdotally by some women on GLP-1 medications. These usually normalize after the first 8-12 weeks. Both providers can address cycle questions through clinician messaging, with Hers having more women-focused content on the topic.<\/p>\n Bottom line: Both providers run async-first clinical models with similar clinician access<\/p>\n Hers and Hims are brands within the same company (Hims & Hers Health, HIMS on NYSE). Products and pricing are similar; marketing and content differ by gender.<\/p>\n Generally no. Compounded semaglutide is the main GLP-1 option. Patients who want tirzepatide need a different provider.<\/p>\n Entry pricing for compounded semaglutide is similar, both around $199 per month. Promotional first-month rates at Hers can drop below $99 but revert.<\/p>\n The active ingredient (semaglutide) is the same at both providers, sourced from licensed US compounding pharmacies. Inactive ingredients may vary by pharmacy partner.<\/p>\n No. Both are cash-pay only. HSA and FSA reimbursement is sometimes possible for diagnosed obesity (BMI 30+) or type 2 diabetes.<\/p>\n If you’ll use cycle tracking, hormonal content, and women’s health information alongside weight loss, the Hers bundle has value. If you only want the medication and clinician access, TrimRx delivers that more directly.<\/p>\n Yes. TrimRx is unisex, unlike men-only providers like Fella Health or women-only providers like Hers.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" Hers is the women-focused side of the Hims & Hers Health platform (HIMS on NYSE).<\/p>\n","protected":false},"author":11,"featured_media":93463,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"TrimRx vs Hers: Complete 2026 Comparison","_yoast_wpseo_metadesc":"Hers is the women-focused side of the Hims & Hers Health platform (HIMS on NYSE).","_yoast_wpseo_focuskw":"trimrx hers","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[21],"class_list":["post-90871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1","tag-comparisons"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=90871"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90871\/revisions"}],"predecessor-version":[{"id":91987,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/90871\/revisions\/91987"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/93463"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=90871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=90871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=90871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Is TrimRx?<\/h2>\n
How Do TrimRx and Hers Compare on Price?<\/h2>\n
Which Medications Does Each Provider Offer?<\/h2>\n
Are There Women-specific Considerations for GLP-1 Medications?<\/h2>\n
How Does the Clinician Experience Compare?<\/h2>\n
What’s Included with Each Program?<\/h2>\n
How Do Customer Reviews Compare?<\/h2>\n
Which Is Better for Weight Loss Outcomes?<\/h2>\n
Which One Should You Choose?<\/h2>\n
How Does Each Provider Handle PCOS, Perimenopause, and Other Women-specific Considerations?<\/h2>\n
How Does Each Provider Address Common Women’s Health Concerns in Trial Data?<\/h2>\n
FAQ<\/h2>\n
Is Hers Different From Hims?<\/h3>\n
Does Hers Offer Tirzepatide?<\/h3>\n
Which Is Cheaper?<\/h3>\n
Are the Medications the Same?<\/h3>\n
Does Either Accept Insurance?<\/h3>\n
Are Hers’ Women-specific Features Useful?<\/h3>\n
Can Men Use TrimRx?<\/h3>\n